Setting up Multiplex Panels for Genetic Testing of Familial Hypertrophic Cardiomyopathy Based on Linkage Analysis
-
Hoorieh SAGHAFI
,
Majid HAGHJOO
,
Sima SABBAGH
,
Niloofar SAMIEE
,
Farve VAKILIAN
,
Mohammad TAGHI SALEHI OMRAN
,
Masoomeh DADASHI
,
Ahmad AMIN
,
Mohammad KERAMATIPOUR
Abstract
Background: Familial hypertrophic cardiomyopathy (HCM) is caused by mutations in genes encoding cardiac sarcomere proteins. Nowadays genetic testing of HCM plays an important role in clinical practice by contributing to the diagnosis, prognosis, and screening of high-risk individuals. The aim of this study was developing a reliable testing strategy for HCM based on linkage analysis and appropriate for Iranian population.
Methods: Six panels of four microsatellite markers surrounding MYH7, MYBPC3, TNNT2, TNNI3, TPM1, and MYL2 genes (24 markers in total) were selected for multiplex PCR and fragment length analysis. Characteristics of markers and informativeness of the panels were evaluated in 50 unrelated Iranians. The efficacy of the strategy was verified in a family with HCM.
Results: All markers were highly polymorphic. The panels were informative in 96-100% of samples. Multipoint linkage analysis excluded the linkage between the disease and all six genes by obtaining maximum LOD score ≤-2.
Conclusion: This study suggests a reliable genetic testing method based on linkage analysis between 6 sarcomere genes and familial HCM. It could be applied for diagnostic, predictive, or screening testing in clinical setting.
Maron BJ, Gardin JM, Flack JM, Gidding SS, Ku¬rosaki TT, Bild DE (1995). Preva-lence of hy¬pertrophic cardiomyopathy in a general popu¬lation of young adults. Echocardiographic analysis of 4111 sub-jects in the CARDIA Study. Coronary Ar-tery Risk Development in (Young) Adults. Circulation, 92: 785-9.
Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE (1980). Sudden death in young athletes. Circulation, 62 : 218-29.
Bos JM, Towbin JA, Ackerman MJ (2009). Diag¬nostic, prognostic, and therapeutic implica¬tions of genetic testing for hyper-trophic cardi¬omyopathy. J Am Coll Cardiol, 54(3): 201-11.
Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Du¬bourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M (2003). Hyper-trophic cardiomyopathy: dis¬tribution of disease genes, spectrum of muta¬tions, and implications for a molecular diagno-sis strategy. Circulation, 107: 2227-32.
Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ (2005). Sarcomeric genotyping in hy¬pertrophic cardiomyopa-thy. Mayo Clin Proc, 80: 463-9.
Jongbloed RJ, Marcelis CL, Doevendans PA, Schmeitz-Mulkens JM, Van Dockum WG, Geraedts JP, Smeets HJ (2003). Var-iable clini¬cal manifestation of a novel mis-sense mutation in the alpha-tropomyosin (TPM1) gene in fa¬milial hypertrophic car-diomyopathy. J Am Coll Cardiol, 41(6): 981-6.
Stenson PD, Mort M, Ball EV, Howells K, Phil¬lips AD, Thomas NS, Cooper DN (2009). The Human Gene Mutation Da-tabase: 2008 up¬date. (HGMD® Profes-sional -Release date 29th June 2012). Ge-nome Med, 1(1): 13.
McKenna WJ, Spirito P, Desnos M, Du-bourg O, Komajda M (1997). Experience from clinical genetics in hypertrophic car-diomyopathy: pro¬posal for new diagnos-tic criteria in adult mem¬bers of affected families. Heart, 77(2): 130-2.
Broman KW, Murray JC, Sheffield VC, White RL, Weber JL (1998). Comprehen-sive human ge¬netic maps: individual and sex-specific varia¬tion in recombination. Am J Hum Genet, 63: 861-9.
Polymeropoulos MH, Xiao H, Rath DS, Merril CR (1991). Dinucleotide repeat polymorphism at the human cardiac beta-myosin gene. Nucleic Acids Res, 19: 4019.
Fougerousse F, Dufour C, Roudaut C, Beckmann JS (1992). Dinucleotide repeat polymorphism at the human gene for cardiac beta-myosin heavy chain (MYH6). Hum Mol Genet, 1: 64.
Anonymous. National Center for Biotech-nology Information (Internet) Available from: http://www.ncbi.nlm.nih.gov/unists
Lindner TH, Hoffmann K (2005). Easylink-age: A PERL script for easy and automat-ed two-/multi-point linkage analyses. Bio-informatics, 21: 405-7.
Wheeler M, Pavlovic A, DeGoma E, Salis-bury H, Brown C, Ashley EA (2009). A new era in clin¬ical genetic testing for hy-pertrophic cardiomy¬opathy. J Cardiovasc Transl Res, 2(4): 381-91.
Dames S, Durtschi J, Geiersbach K, Ste-phens J, Voelkerding KV (2010). Com-parison of the Il¬lumina Genome Analyzer and Roche 454 GS FLX for resequencing of hypertrophic cardio¬myopathy-associated genes. J Biomol Tech, 21(2): 73-80.
Meder B, Haas J, Keller A, Heid C, Just S, Borries A, et al (2011). Targeted next-generation se¬quencing for the molecular genetic diagnostics of cardiomyopathies. Circ Cardiovasc Genet, 4(2): 110-22.
Van Driest SL, Will ML, Atkins DL, Acker-man MJ (2002). A novel TPM1 mutation in a family with hypertrophic cardiomyo-pathy and sud¬den cardiac death in child-hood. Am J Cardiol, 90(10): 1123-7.
Tirone AP, Arteaga E, Pereira Ada C, Krieg-er JE, Buck Pde C, Ianni BM, Mady C (2005). Re¬search of markers for the genes of the heavy chain of cardiac beta-myosin and myosin bind¬ing protein C in relatives of patients with hy¬pertrophic cardiomyo-pathy. Arq Bras Cardiol, 84(6): 467-72.
Abid A, Akhtar N, Khaliq S, Mehdi SQ (2011). Genetic heterogeneity for auto-somal domi¬nant familial hypertrophic cardiomyopathy in a Pakistani family. J Coll Physicians Surg Pak, 21(4): 202-6.
Mogensen J, Andersen PS, Steffensen U, Christi¬ansen M, Egeblad H, Gregersen N, et al (2001). Development and applica-tion of link¬age analysis in genetic diagno-sis of familial hy¬pertrophic cardiomyopa-thy. J Med Genet, 38(3): 193-8.
| Files | ||
| Issue | Vol 45 No 3 (2016) | |
| Section | Original Article(s) | |
| Keywords | ||
| Cardiomyopathy Hypertrophic Genetic linkage Diagnosis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
